Literature DB >> 26605506

Nutritional and Immunological Correlates of Memory and Neurocognitive Development Among HIV-Infected Children Living in Kayunga, Uganda.

Horacio Ruiseñor-Escudero1, Itziar Familiar-Lopez, Alla Sikorskii, Nikita Jambulingam, Noelline Nakasujja, Robert Opoka, Judith Bass, Michael Boivin.   

Abstract

OBJECTIVE: To identify the nutritional and immunological correlates of memory and neurocognitive development as measured by the Mullen Scales of Early Learning (MSEL) and by the Color Object Association Test (COAT) among children in Uganda.
DESIGN: This analysis uses baseline data collected between 2008 and 2010 from 119 HIV-infected children aged 1-6 years, participating in a randomized controlled trial of an interventional parenting program in Kayunga, Uganda.
METHODS: Peripheral blood draws were performed to determine immunological biomarkers. Unadjusted and adjusted linear regression models were used to relate MSEL and COAT scores to sociodemographic characteristics, weight-for-age Z scores (WAZs), antiretroviral therapy status, and immunological biomarkers.
RESULTS: In the final analysis, 111 children were included. Lower levels of CD4 CD38 T cells (P = 0.04) were associated to higher immediate and total recall scores (P = 0.04). Higher levels of CD8 HLA-DR T cells were associated with higher total recall score (P = 0.04) of the COAT. Higher CD4 CD38 HLA-DR T cells levels were associated with higher gross motor scores of the MSEL (P = 0.02). WAZ was positively correlated to visual reception, fine motor, expressive language, and composite score of the MSEL.
CONCLUSIONS: Overall, WAZ was a stronger predictor of neurocognitive outcomes assessed by the MSEL. CD4 CD38 T cells were more specifically associated with memory-related outcomes. Future research should include immunological markers and standardized neurocognitive tests to further understand this relationship.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26605506      PMCID: PMC4788522          DOI: 10.1097/QAI.0000000000000905

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  34 in total

1.  Neuropsychological evaluation of neurologically asymptomatic HIV-infected children.

Authors:  P S Bisiacchi; A Suppiej; A Laverda
Journal:  Brain Cogn       Date:  2000 Jun-Aug       Impact factor: 2.310

2.  Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets.

Authors:  T W McCloskey; N Kohn; M Lesser; S Bakshi; S Pahwa
Journal:  Cytometry       Date:  2001-06-15

3.  Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection.

Authors:  D Drotar; K Olness; M Wiznitzer; L Guay; L Marum; G Svilar; D Hom; J F Fagan; C Ndugwa; R Kiziri-Mayengo
Journal:  Pediatrics       Date:  1997-07       Impact factor: 7.124

4.  Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV.

Authors:  Heena Brahmbhatt; Michael Boivin; Victor Ssempijja; Godfrey Kigozi; Joseph Kagaayi; David Serwadda; Ronald H Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

5.  Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.

Authors:  Rita J Jeremy; Soyeon Kim; Molly Nozyce; Sharon Nachman; Kenneth McIntosh; Stephen I Pelton; Ram Yogev; Andrew Wiznia; George M Johnson; Paul Krogstad; Kenneth Stanley
Journal:  Pediatrics       Date:  2005-02       Impact factor: 7.124

6.  HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO Group.

Authors:  M Tardieu; J Le Chenadec; A Persoz; L Meyer; S Blanche; M J Mayaux
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

7.  Cognitive assessment of human immunodeficiency virus-exposed children.

Authors:  R L Levenson; C A Mellins; R Zawadzki; R Kairam; Z Stein
Journal:  Am J Dis Child       Date:  1992-12

8.  Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Authors:  Silvia Sánchez-Ramón; José Ma Bellón; Salvador Resino; Carmen Cantó-Nogués; Dolores Gurbindo; José-Tomás Ramos; Ma Angeles Muñoz-Fernández
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

9.  A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children.

Authors:  M J Boivin; S D Green; A G Davies; B Giordani; J K Mokili; W A Cutting
Journal:  Health Psychol       Date:  1995-01       Impact factor: 4.267

10.  Developmental abnormalities in children with acquired immunodeficiency syndrome (AIDS): a follow-up study.

Authors:  M H Ultmann; G W Diamond; H A Ruff; A L Belman; B E Novick; A Rubinstein; H J Cohen
Journal:  Int J Neurosci       Date:  1987-02       Impact factor: 2.292

View more
  3 in total

1.  Quality of Caregiving is Positively Associated With Neurodevelopment During the First Year of Life Among HIV-Exposed Uninfected Children in Uganda.

Authors:  Itziar Familiar; Shalean M Collins; Alla Sikorskii; Horacio Ruisenor-Escudero; Barnabas Natamba; Paul Bangirana; Elizabeth M Widen; Daniel Achidri; Harriet Achola; Daniel Onen; Michael Boivin; Sera L Young
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

2.  Scaling up Pediatric HIV Testing by Incorporating Provider-Initiated HIV Testing Into all Child Health Services in Hurungwe District, Zimbabwe.

Authors:  Reuben Musarandega; Blessing Mutede; Agnes Mahomva; Wenceslas Nyamayaro; Angela Mushavi; Christina Lindan; Rhoderick Machekano
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

3.  High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study.

Authors:  Yihun Mulugeta Alemu; Gashaw Andargie; Ejigu Gebeye
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.